Materials and Methods
Mice . With the exception of some of the animals used for virus titrations, all mice were from our own colony of highly inbred mouse strains. The congenic mouse strain referred to as BALB .B, was established from the (BALB/c x C57BL/10)F, cross. This strain was inbred after 13 consecutive backcrosses to the BALB/c parental strain with selection in each generation for the H-2°haplotype of the C57BL/10 ancestor. Thus, any differences observed between BALB/c and BALB .B mice can be attributed with high probability to a gene or genes in the immediate vicinity of the H-2 region of linkage group IX (chromosome 17).
For virus titrations, DBA/2Ha, random-bred Ha/ICR Swiss and BALB/c mice were obtained from the West Seneca Laboratories, Buffalo, N. Y. Animals were usually 6-to 10-wk old at the time of virus inoculation .
Viruses. The variant N-.NB-tropic strain of FV was used throughout these experiments . This virus strain %as derived from the original N-tropic FV by forced passage in BALB/c mice (4) . N-NB-tropic FV is equally infective in DBA/2 and BALB/c (Fv-1") mice and their F, hybrids. Preparations of FV were obtained from the greatly enlarged spleens of BALB/c mice infected 2 wk previously with N-.NB-tropic FV from a syngeneic donor. The spleens were homogenized in nine times their weight of cold phosphate-buffered saline (PBS). After slow centrifugation at 4°C to remove large particulate matter from the homogenate, the supernate was recentrifuged for 4 min at 7,000 g. The resulting supernate was stored in small ampules at -70°C and served as the basic virus preparation . When assayed in BALB/c mice, such preparations usually show a titer of about 5 x 10' spleen focus-forming units (SFFU)/ml.
A lymphatic leukemia virus was isolated from N-tropic FV (LLV-F) by passage into newborn C57BL (Fv-l') mice followed by blind passage in weanling Ha/ICR swiss mice (5) . Conversion to NB tropism occurred during five subsequent serial passages in BALB/c mice . All LLV-F stocks were free of detectable spleen focus-forming activity . Moloney leukemia virus (MoILV) was obtained in 1964 from Dr . J. B. Moloney, National Cancer Institute, Bethesda, Md . This virus was considered NB tropic after four passages in BALB/c mice. Stocks of LLV-F and Mo1LV were prepared as 20% perfusates of leukemic BALB/c spleens. Enlarged spleens were pooled and perfused with McCoy's medium containing 3% fetal calf serum, and the fluids were clarified at 2,400 g for 10 min and stored at -196°C . Stocks of LLV-F and of Mo1LV were titrated for their helper activity for SFFV by the method of Steeves et al . (6) and showed 8 x 10' and 9 x 10 9 helper U/ml, respectively . Virus Assays . FV was routinely titrated in vivo by the spleen focus assay (7) . Diluted samples were injected into the lateral tail veins of mice in 0.5-ml vol. 9 days later the spleens of the recipients were excised, fixed in Bouin's solution, and examined for discrete, macroscopic, focal lesions on the splenic surfaces . Virus titers were expressed in SFFU per milliliter .
Titrations in vitro of virus samples were performed by the XC plaque assay (8) . For this assay, embryo fibroblasts of the NIH Swiss (Fv-1") and BALB/c (Fv-1°) strains were obtained from Microbiological Associates, Inc., Bethesda, Md . In addition embryo fibroblasts of the BALB/c and DBA/2 (Fv-1") strains were obtained from animals in our own colony . Virus titers were expressed in plaque-forming units (PFU) per milliliter .
Tissue Culture. All cell lines grown in culture were established from their respective subcutaneous solid tumors . These lines consisted of nonadherent cells maintained in stationary suspension culture. Adherent cells were discarded. Essentially, tissue fragments from the various tumors were minced in Eagle's minimum essential medium (MEM) with Earle's base plus glutamine (MEM-Earle's), filtered through sterile gauze, and the resulting cell suspension washed five to six times in MEM-Earle's. These cells were resuspended at a concentration of 5 x 108 cells/ml in complete growth medium : MEM-Earle's containing 20% fetal calf serum, extra L-glutamine (0.58 mg/ml total), 100 U/ml penicillin, and 100 mcg/ml streptomycin . T-30 flasks were seeded with 5 ml of the cell suspensions and incubated at 37°C . After 24 h each culture was diluted fivefold with complete growth medium and the cells redistributed in 5-ml vol into new T-30 flasks . The cells were then maintained at a concentration of 5 x 10 8 celWml by periodic dilution with fresh growth medium . Within 3 wk the cells in successful cultures appeared to be well adapted to growth in vitro. Thereafter, the cells were maintained in complete growth medium containing 10% fetal calf serum and 0.292 mg/ml L-glutamine by planting 5-ml vol containing 5 x 10' cells/ml in T-30 flasks followed by subculturing when the cell concentration reached 5 x 10°cells/ml (approximately 5 days). This same growth medium was used for all cocultivation experiments as well .
Results
Derivation of BALB/c Tumor: HFL/d. 25-28 days after infection of a BALB/c female mouse with N,NB-tropic FV, washed fragments of the greatly enlarged spleen were transplanted subcutaneously to syngeneic hosts. Such implants usually enlarged slowly but progressively . In the early transplant generations, the recipients showed a concomitant primary FV-disease syndrome as well as growth of the transferred tumor cells. For this reason it was important to transfer the tumor at 7-to 14-day intervals, even though the tumors were relatively small at this time . In later transplant generations, the transfer of infectious virus with the tumor cells appeared much diminished, since the accompanying primary disease syndrome seemed weaker or occasionally nonexistent . In addition, the growth of the transplanted tumors appeared to become more rapid in later generations. Grossly, this tumor resembled those produced originally by Buffett and Furth (9) and by Friend and Haddad (10) by similar methods . This tumor has been designated HFL/d-sc ; "d" refers to the H-2d type of the mice from which this tumor was derived, and "sc" refers to subcutaneous passage.
Derivation of BALB .B Tumor: HFL/b. The transplantable subcutaneous tumor, HFL/b-sc, was induced in a congenic BALB .B female mouse . This tumor was established in essentially the same manner as the H-2-congenic HFL/d-sc tumor. However, it is notable that transfers of BALB .B-infected spleen fragments showed only transient growth followed by tumor rejection in normal syngeneic hosts, so that the tumor line could not be established in these hosts . When the recipients were rendered anemic by bleeding (-0.3 ml three times a week), beginning the day of transplantation, the transplants showed much more reliable progressive growth (Table 1) (Table II) HFL/b-tc cells rarely induced progressively growing tumors in normal syngeneic hosts . Rather, it was necessary to render the mice anemic by bleeding in order to achieve tumor growth in vivo, as noted previously with regard to the HFL/b-sc tumor line. A detailed study of the growth properties in vivo of HFL/d-tc and HFL/b-tc cells will be the subject of a subsequent paper.
Wright-stained preparations (11) of HFL/d-tc and HFL/b-tc cells revealed at least three cell types. The most abundant cell appeared to be a proerythroblast exhibiting a high nucleocytoplasmic ratio, deep blue-staining cytoplasm, nuclear hyperchromatism, and coarse chromatin aggregates . Although most cells contained a single round nucleus, occasional binucleate forms were present .
The second cell type appeared somewhat larger than the proerythroblast with paler staining nucleus and cytoplasm. Nuclear chromatin was arranged in a fine, open meshwork containing two to four large irregularly shaped nucleoli . Such cells resemble very closely those described by Friend et al. (11) and referred to as primitive reticulum or "stem" cells. Mitoses were frequently observed among both proerythroblasts and reticulum cells.
Erythroblasts in more advanced stages of maturity were present as well, although reticulocytes or fully mature anucleate erythrocytes were absent . Accordingly, the most advanced stage observed appeared identical to the basophilic erythroblasts described by Friend et al. (11) finding is consistent with the fact that the tumor was originally induced by N,NB-tropic FV .
When these tumor cells were grown in culture (HFL/d-tc), FV detectable by the spleen focus assay in vivo was revealed in supernatant fluids . Virus persisted for at least 13 weekly passages, showing titers in the range of 10z-10 3 SFFU/ml culture supernate 6 days after subculture . At the 16th and subsequent passages FV could no longer be detected in supernates by the spleen focus assay. These supernates were also virus negative when assayed in vitro by the XC method (Table III, (Table 111, B1 ) . Since Mo1LV itself shows no activity in the spleen focus assay, it appears that SFFV was rescued from HFL/d-tc cells during their residence in helper virus-infected hosts .
Attempts to recover FV in vitro were made as well . Syngeneic embryo fibroblasts infected in culture with NB-tropic Mo1LV were grown as monolayers and allowed to reach approximately 80% confluence . At this point HFL/d-tc cells taken from the 34th passage were added to these fibroblast cultures . After cocultivation for 7 days, supernates were removed and tested for spleen focus-forming activity . These tests showed NB-tropic virus at a concentration of approximately 24 SFFV/ml, confirming in vitro the rescue of SFFV by helper virus (MoILV) already demonstrated in vivo .
Observations during the course of cocultivation suggested that a number of HFL/d-tc cells adhered to areas of the fibroblast monolayers . These adherent cells were not dislodged by vigorous agitation. With this in mind, cocultivation was repeated using either NB-tropic Mo1LV or NB-tropic LLV-F-infected syngeneic fibroblasts . All fibroblasts were infected in vitro. This time, however, during the course of cocultivation with HFL/d-tc cells harvested from the 40th passage generation, supernatant fluids were decanted daily, and replaced with fresh growth media. Although this procedure resulted in the loss of many nonadherent cells, supernatant fluids tested 7 days after the initiation of cocultivation with MoILV-infected fibroblasts showed 100 SFFU/ml. Supernatant fluids harvested from parallel cultures of HFL/d-tc cells with LLV-Finfected fibroblasts contained 200 SFFU/ml (Table III, (Table III, C1) .
In order to confirm this phenomenon, 1 x 10 5 HFL/d-tc cells of the 33rd passage were transplanted intraperitoneally to syngeneic hosts. Serial passage in vivo resulted in the establishment of the ascitic HFL/d-as2 cell line . This time hosts harboring the third serial passage generation (57 days after initiating of the cell line) displayed splenomegaly . Extracts of these spleens showed NB-tropic FV at a concentration of 1.2 x 10 6 SFFU/ml when assayed in vivo and NB-tropic virus at a concentration of 2.5 x 10 6 PFU/ml when assayed by the XC method (Table III, C2) .
It should be emphasized that, although mice carrying HFL/d-as cells demonstrate FV in their spleens, the HFL/d-as cells recovered from the peritoneal cavity did not appear to be actively producing virus. When HFL/d-as cells, harvested from the peritoneal cavity of viremic hosts, were carefully washed before inoculation into the peritoneal cavity of normal syngeneic hosts, no splenomegaly was observed until the third serial intraperitoneal passage. Similarly, HFL/d-as2 cells maintained in vivo for six passage generations and then returned to culture showed no virus activity when supernatant fluids were assayed in vivo or in vitro (Table III, C3 and C4) . When after a total of six serial passages in vitro, these cells were returned to the peritoneal cavity of syngeneic hosts and passed serially, host splenomegaly did not reappear until approximately 87 days after reinitiation of intraperitoneal passage (fifth passage generation) .
Discussion
We have established cell lines in culture from tumors derived from the enlarged spleens of FV-infected BALB/c (H-2d) and congenic BALB .B mice . Morphologically these cell lines, as well as the tumors from which they were derived, resemble those produced with similar techniques in other laboratories (9) (10) (11) (12) (13) (14) (15) (16) . Cultures of these cells are composed of red cell precursors in various stages of differentiation. This description is consistent with the observation that treatment of these cultures with dimethylsulfoxide results in an increase in both the number of benzidine-positive cells and the total amount of detectable hemoglobin (reference 17, and M. Adesnick, unpublished observation) . Thus, the hematopoietic potential of these cultures has been established. The malignancy potential of these cells was demonstrated by the formation and progressive growth in situ of solid tumors after inoculation into syngeneic hosts.
When BALB/c tumors (HFL/d-sc) and their cultured counterparts (HFL/d-tc) were assayed for production of FV, only solid tumor extracts and supernates from early passages in culture gave positive results . Subsequent passages in vitro revealed no infectious virus by either XC or spleen focus assays . In contrast, supernates of cultures derived from BALB .B tumors persistently exhibited infectious virus detectable in both XC and spleen focus assays . The nonproducer status of HFL/d-tc cells corroborates and expands upon the results of Fieldsteel et al . (15, 18, 19) , who have also found that tumor cells,derived from FV-infected BALB/c mice fail to produce virus in vitro.
In addition to infectivity assays, demonstration of virus-like particles with a density of 1 .16 g/cm 3 and virus-associated reverse transcriptase activity confirmed the presence of virus in HFL/b-tc culture supernates of the 28th, 38th, and subsequent passage generations . Neither virus-like particles nor reverse transcriptase activity were found in HFL/d-tc cultures (M . Adesnick, unpublished observations) . No intra-or extracellular virus-like particles could be seen electron microscopically in thin sections of HFL/d-tc cells. In contrast similar preparations of HFL/b-tc cells showed C-type particles, both extracellularly and budding from the cell surface (S . Panem, unpublished observation) .
The cell lines that we have established differ genotypically from each other only with respect to the H-2 region of chromosome 17 (linkage group IX). Nonproducer HFL/d-tc cells originated from a BALB/c mouse and possess the H-2d haplotype; producer HFL/b-tc cells are of congenic BALB .B origin and possess the H-2°haplotype derived from C57BL/10 mice . It is tempting to speculate that this genotypic difference is the basis for the marked difference in virus production noted between the two cell lines, but at this time it remains possible that other factors are involved in these observations . Further studies will be required to elucidate this point.
FV is a complex consisting of a spleen focus-forming component (SFFV) and an associated helper (5, 19, 20) In these studies we have employed both the spleen focus and XC assays . The spleen focus assay was used because it is specific for complete FV, i.e., spleen foci are induced by SFFV only in the presence of helper virus. The XC assay, on the other hand, is capable of measuring helper virus even in the absence of SFFV. Since the results obtained by both methods were comparable, both components of FV were expressed coordinately .
Curiously, we were unable to establish the BALB.B tumor (HFL/b-sc) in normal BALB .B hosts. Fragments of FV-infected BALB.B spleens failed to grow progressively upon transplantation to normal BALB.B mice. However, when BALB.B recipients were rendered anemic by bleeding during the course of tumor derivation, the BALB.B tumor was readily established. Transplants of BALB.B tumors (HFL/b-sc) or their cultured counterparts (HFL/b-tc) consistently regressed except in anemic hosts.
Although the mechanism of this effect of bleeding on tumor growth in BALB.B hosts is as yet undetermined, two possible explanations can be postulated . One explanation might be that the anemia induced by bleeding results in increased levels of circulating erythropoietin which in turn stimulates the growth of transplanted FV-transformed red cell precursors . This possibility would agree with earlier studies indicating that erythropoietin increases susceptibility to FV by increasing the number or the susceptibility of target cells (i .e ., erythropoietinsensitive primitive erythroid cells) before transformation (23) . Another possible explanation is that bleeding not only decreases humoral antibody levels but also removes migrating immunocytes which reject the tumor cells . In fact, both mechanism may be operating in concert . 
